Cristina Abreu

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

Relationship between “a body shape index (ABSI)” and body composition in obese patients with type 2 diabetes

Fernando Gómez‐Peralta, Cristina Abreu, Margarita Cruz-Bravo et al. · Diabetology & Metabolic Syndrome · 2018 · 99 citations · Full text

Medicine, Endocrinology, Nutrition +17

Use of combination therapy is associated with improved LDL cholesterol management: 1-year follow-up results from the European observational SANTORINI study

Kausik K. Ray, Carlos Aguíar, Marcello Arca et al. · European Journal of Preventive Cardiology · 2024 · 70 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Incidence and care‐related costs of severe hypoglycaemia requiring emergency treatment in Andalusia (Spain): the <scp>PAUEPAD</scp> project

Rafael J. Barranco, Fernando Gómez‐Peralta, Cristina Abreu et al. · Diabetic Medicine · 2015 · 51 citations · Full text

Health Professions, Emergency Medical Services, Emergency Medicine +12